MedTrace Logo

Open-Label Placebo for Non-Specific Pain in the ED

NCT06408519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2026-03-09

No results posted yet for this study

Summary

The aim of this study is to assess whether an intervention with open-label placebo (OLP) for non-specific pain in the emergency department is feasible.

Conditions

  • Pain, Acute

Interventions

OTHER

Placebo (open-label)

P-Tabletten weiss 10mm (Lichtenstein, Zentiva) pills 3x/day

DRUG

Ibuprofen 400 mg

Ibuprofen pills 3x/day

Sponsors & Collaborators

  • Roland Bingisser, Principal Investigator, Head of Emergency Department, University Hospital Basel

    collaborator UNKNOWN

  • Jens Gaab, Co-investigator, Head of Division University of Basel, Faculty of Psychology

    collaborator UNKNOWN

  • Bojana Degen, Co-investigator, University of Basel, Faculty of Psychology

    collaborator UNKNOWN

  • Anna Szczesna, Co-investigator, University Hospital Basel, Emergency Department

    collaborator UNKNOWN

  • Christian H Nickel, Co-investigator, Deputy Head of Emergency Department, University Hospital Basel

    collaborator UNKNOWN

  • Bruno Minotti

    lead OTHER

Principal Investigators

  • Bruno Minotti, MD · Emergency Department, University Hospital Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-23
Primary Completion
2026-02-13
Completion
2026-02-13

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408519 on ClinicalTrials.gov